CD8A and neoplasm: As eradication of tumor cells in vivo is most efficiently performed by CD8+ and/or CD4-CD8- natural killer (NK) cytolytic T lymphocytes (CTL) [7,8], various methods for increasing recognition by lymphocytes have been developed.